Background: Atherosclerosis begins as local inflammation of vessels at sites of disturbed flow, where low shear stress (LSS) leads to mechanical irritation and plaque development and progression. Nuclear enzyme poly(ADP-ribose) polymerase 1 (PARP-1) is associated with the inflammation response during atherosclerosis. We investigated the role and underlying mechanism of PARP-1 in LSS-induced inflammation in human umbilical vein endothelial cells (HUVECs). 
Introduction
Atherosclerosis is a complicated chronic inflammation in arteries resulting from interaction between immune mechanisms and metabolic risk factors. [1] It primarily affects large and medium-sized arteries in a site-specific manner, with a predilection to the inner wall of curvatures and outer wall of bifurcations. [2] Numerous studies suggest that local hemodynamic forces play a major role in regulating the site-specific predilection of atherosclerosis, and the most important one is called wall shear stress. [3] Wall shear stress is a frictional force exerted parallel to the arterial wall by the wall shear rate and viscosity of blood. [4] Undisturbed shear stress (USS) ranges from 0.5 to 1.2 Pa, and values below and above this range are thought to indicate low shear stress (LSS) and increased shear stress, respectively. [5] Wall shear stress acts on endothelial cells and leads to activation of various cell signaling molecules, such as protein kinase C (PKC), mitogen-activated protein kinase (MAPK) and so on. [6] LSS promotes mass transport of atherogenetic substances between the lumen and the arterial wall to induce atherosclerosis and predicts plaque development. [7] Poly(ADP-ribose) polymerase 1 (PARP-1) is a highly conserved DNA-binding nuclear enzyme that can be activated by oxidative DNA damage mainly by ROS. [8] Upon DNA damage, PARP-1 binds to DNA strand breaks and catalyses the addition of long branched chains of poly(ADP-ribose) (PAR, the product of PARP-1) to a number of nuclear proteins. Excessive activation of PARP-1 leads to intracellular depletion of NAD and ATP, thus resulting in cellular energy crisis, irreversible cytotoxicity and cell death. [9] Moreover, PARP-1 is a co-activator of nuclear factor-κB (NF-κB) and can regulate the expression of various key inflammatory genes, including inducible nitric oxide synthase (iNOS), intercellular adhesion molecule 1 (ICAM-1), and vascular cell adhesion molecule 1, all of which are regulated by NF-κB. [10] Excessive activation of PARP-1 is closely associated with the pathogenesis of cardiovascular diseases.
Pharmacological inhibition or genetic deletion of PARP-1 can protect against
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4 endothelial dysfunction, reduce inflammation and atherosclerotic plaque size, and promote factors of plaque stability.
Class Ⅲ histone deacetylases (HDACs), also called sirtuins or Sirts, constitute a special group of enzymes that require NAD in their deacetylation reaction. [11] Sirt1 is a prototype member of the sirtuins family, which has been implicated in transcriptional silencing, genetic control of aging, cell metabolism, and calorie restriction-mediated longevity of the organism. [12] Studies have suggested that Sirt1 can promote cell survival and may protect cells against oxidative stress. [13, 14] However, previous studies focused on the role of PARP-1 in ox-LDL induced atherosclerosis, little was known about the relationship between PARP-1 and low shear stress, we aimed to investigate the role and underlying mechanism of PARP-1 in LSS-induced inflammation in HUVECs.
Materials and Methods
Cell culture, flow system and genes inhibition
HUVECs (ATCC, USA) were cultured in endothelial cell medium (ECM, ScienCell, CA, USA) supplemented with 5% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 ug/ml streptomycin at 37°C up to passage 4 and seeded onto gelatin-coated slides. A parallel-plate flow system was used to impose LSS (0.4 Pa). [15] We used SP600125, SB203580, and U0126 (Cell Signaling Technology, MA, USA) to inhibit the activity of JNK, p38, and ERK. To inhibit PARP-1 expression, HUVECs were treated with ABT888 [16] or transiently transfected with siRNA negative control (si-NC) or si-PARP-1 (GenePharma) in Optimem Medium (Invitrogen, CA, USA) with use of Lipofectamine 2000 (Invitrogen). Experiments were performed 24 hrs after transfection.
RT-PCR
RNA was extracted from HUVECs by use of Trizol (Invitrogen). cDNA generated by RT-PCR was analyzed by real-time RT-PCR with iQ TM SYBR Green Supermix (Bio-Rad Laboratories, CA, USA). Each sample was analyzed in triplicate, and expression was normalized to that of GAPDH. The primers for iNOS were as follows:
forward, 5-GTTCTCAGCCCAACAATACAAGA-3; reverse, 5-GTGGACGGGTCGATGTCAC-3; for ICAM-1: forward, 
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O 2 -production
To measure O 2 -production in HUVECs, we used dihydroethidium (DHE) (Beyotime, Beijing) as described. [17] Shear-preconditioned and static cells were incubated in 5
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Comet assay
DNA damage induced by LSS was assessed by comet assay using comet assay kit 
Electrophoretic mobility shift assay (EMSA)
EMSA was performed by using LightShift Chemiluminescent EMSA kit (Thermo Scientific) according to the manufacturer's instructions. Briefly, HUVECs were collected and nuclear proteins were extracted by nuclear extraction kit (active motif, CA, USA). Single-stranded oligonucleotides containing binding sites of NF-κB (5-AGTTGAGGGGACTTTCCCAGGC-3) were synthesized and endlabeled with biotin (Biosune, Shanghai, China). Single-stranded oligonucleotides were annealed to double-strand probes for EMSA. Nuclear protein (5 μg) was incubated with 20 fmol biotin-labeled oligonucleotides for 20 min at room temperature in binding buffer consisting of 50mM KCl,10mM EDTA, 2.5% glycerol, 5mM MgCl 2 , 50ng poly(dI·dC), and 0.05% NP-40. The specificity of the NF-κB-DNA binding was determined in competition reactions in which a 200-fold molar excess (4pmol) of unlabeled oligonucleotide was added. After electrophoresis in 6.5% PAGE using 0.5× TBE buffer, protein-oligonucleotide complex was electroblotted to a positively charged nylon membrane. Then transferred DNA was crosslinked to membrane with a UV lamp for 10 min. After incubation in blocking buffer for 15 min at room temperature, the membrane was washed and incubated with Substrate Equilibration Buffer for 10 min at room temperature. The membrane was then incubated with chemiluminescent substrate for 5 min before analyzed in ImageQuant LAS 4000 mini (GE healthcare). 
Statistical analysis
0.05 was considered to indicate statistical significance.
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Results
Time-dependent regulation of inflammatory factors by LSS in HUVECs
HUVECs were stimulated by LSS (0. Figure 1 ). We used HUVECs stimulated by LSS for 12 hr for further experiments.
LSS increased PARP-1 expression and activity in HUVECs
We used PARP-1 siRNA and PARP-1 inhibitor ABT888 in following experiment. To Figure   2C and 2D). Moreover, LSS could significantly increase PAR formation, while ABT888
or si-PARP-1 attenuated it (p<0.05, Figure 2C and 2E).
O 2 -production and 3-NT formation were upregulated by LSS
As O 2 -and 3-NT can damage DNA which leads to PAR formation, we detected O 2 -production and 3-NT formation with LSS stimulation in HUVECs for 12 hr. O 2 -production and 3-NT formation were significantly increased in LSS-stimulated HUVECs, which suggested that LSS could induce oxidative stress (p<0.05, Figure 3A to 3C).
DNA damage was induced by LSS
DNA damage induced by LSS was determined by H2A.X phosphorylation and comet assay. Histone H2A.X is a variant histone which is required for checkpoint-mediated cell cycle arrest and DNA repair following double-stranded DNA breaks. Various stimulus induced DNA damage can result in rapid phosphorylation of H2A.X. LSS
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11 significantly increased H2A.X phosphorylation (p<0.05, Figure 3D and 3E). Comet assay showed that there was little DNA in tail of static cells, while LSS could increased the percentage of DNA in tail (p<0.05, Figure 3F and 3G).
PARP-1 was activated by LSS via MEK/ERK pathway
We then investigated the mechanism of PARP-1 activation (PAR formation) induced by LSS. LSS could increase the protein expression of p-c-Jun, p-MAPKAPK-2, and p-ERK compared with static (p<0.05, Figure 4A to 4F). Addition of SP600125 (JNK inhibitor), SB203580 (P38 inhibitor), and U0126 (ERK inhibitor) significantly reduced them, but only MEK/ERK inhibition reduced PAR formation (p<0.05, vs. low, Figure 4 ).
The results suggested that the MEK/ERK pathway is involved in LSS induced PARP-1 activation.
Inhibition of PARP-1 attenuated inflammatory factors expression
Considering the critical role of the inflammatory factors in atherogenesis, we measured the effect of PARP-1 inhibition on iNOS and ICAM-1 expression in
HUVECs. LSS stimulation markedly increased iNOS and ICAM-1 expression as compared with static cells (p<0.05, Figure 5A to 5C). After PARP-1 inhibition, iNOS and ICAM-1 expression was significantly reduced (p<0.05, vs. low).
PARP-1 inhibition increased Sirt1 activity by upregulation of NAD + level
Compared with static cells, LSS decreased the Sirt1 expression and activity, while PARP-1 inhibition had no significant effect on Sirt1 expression but increased its activity ( Figure 5A , 5D and 5E). As the activity of Sirt1 depended on NAD + concentration, the effect of PARP-1 on NAD + was determined. Compared with the control, LSS reduced the NAD + concentration, while PARP-1 inhibition by inhibitor or siRNA restored it (p<0.05, Figure 5F ).
PARP-1 inhibition reduced LSS-induced inflammatory factors expression by inhibiting NF-κB nuclear translocation and activity as well as NF-κB phosphorylation
Given that iNOS and ICAM-1 expression depend on NF-κB activation, [19] we
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wondered whether the negative effect of PARP-1 inhibition was associated with defective NF-κB activation. Figure 6A shows that NF-κB p65 was mostly cytoplasmic before LSS stimulation, but its localization quickly changed to the nucleus with LSS stimulation. After PARP-1 inhibition, p65 remained primarily cytoplasmic after LSS treatment. EMSA result showed that LSS could increase NF-κB activity, while PARP-1 inhibition reduced it (p<0.05, Figure 6B ). Then we investigated the underlying mechanism. Western blot analysis showed that LSS reduced the IκBα expression, while PARP-1 inhibition had no effect on it ( Figure 6C and 6D) , which suggested that the defect might reside in the actual translocation of the transcription factor to the nucleus rather than its association with IκBα. Then we measured p-p65 level. LSS could significantly increase p-p65 level compared with static controls, and PARP-1 inhibition reduced it (p<0.05, Figure 6E and 6F).
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Discussion
Atherosclerosis begins with fatty streak formation in an atherogenic background that is caused by the interaction between systemic cardiovascular risk factors and local hemodynamic forces such as LSS. [20] The precise interplay between LSS, vessels and plaque development is still obscure. We focused on the potential role and underlying mechanism of PARP-1 in LSS-induced atherogenesis. In HUVECs, LSS increased superoxide production and nitrotyrosine formation as well as DNA damage.
PARP-1 could be activated by LSS via MEK/ERK-dependent pathway, which resulted in an increased NF-κB activation and iNOS and ICAM-1 expression. PARP-1 plays a critical role in LSS-induced inflammation through a pathway involving a decreased Sirt1 activity and increased inflammatory factors expression.
PARP-1 is a DNA repair-associated nuclear enzyme that is activated in response to DNA damage. [21] It is closely related to various pathological conditions, including heart failure, ischemia-reperfusion injury, hypertension, atherosclerosis, and aging. [22, 23, 24] Accumulating evidence suggests that the endothelial dysfunction in atherosclerosis is related to the local formation of ROS near the vascular endothelium and PARP-1 activation. [25] In our experiment, we found that LSS increased PARP-1 expression and PAR formation. Inhibition of PARP-1 reduced LSS induced inflammation, which meant PARP-1 played a critical role in LSS induced inflammation.
As far as we know, PARP-1 is a DNA damage sensor and can be activated by damaged DNA, but few reports have described the connection between LSS and PARP-1. In our experiment, we demonstrated that LSS could activate a variety of cell signaling transduction molecules, including ERK, JNK, and p38. The expression and/or activity of these signaling molecules were significantly decreased after application of siRNA or inhibitor, but only inhibition of MEK/ERK lead to decreased PARP-1 activation induced by LSS. We firstly showed that LSS could induce PAR formation through MEK/ERK dependent pathway.
We further investigated the potential mechanisms of PARP-1 in LSS-induced After LSS stimulation for 12h, superoxide production was measured by dihydroethidium (DHE) and nitrotyrosine formation was assessed by western blot analysis. DNA damage was determined by H2A.X phosphorylation and comet assay. 
